Who is sponsoring NCT03636789?

NCT03636789 is sponsored by Centre Hospitalier Universitaire de Nīmes.

What drugs are being tested in NCT03636789?

Interventions in NCT03636789: Neurological consultation.

What condition does NCT03636789 study?

NCT03636789 studies Radiologically Isolated Syndrome (RIS), Multiple Sclerosis.

Is NCT03636789 still recruiting?

NCT03636789 is currently completed. Last updated 18 April 2022.

Last reviewed 2022-04-18 · How we verify

NCT03636789: OCRIS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Prevalence of Oculomotor Disorders in Patients With Radiologically Isolated Syndrome

Completed NA Last updated 18 April 2022

What this trial tests

NA trial testing Neurological consultation in Radiologically Isolated Syndrome (RIS) in 61 participants. Completed in 5 November 2021.

Timeline

26 October 2018

Primary endpoint
21 October 2021

5 November 2021

Quick facts

Lead sponsor	Centre Hospitalier Universitaire de Nīmes
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	61
Start date	26 October 2018
Primary completion	21 October 2021
Estimated completion	5 November 2021
Sites	6 locations across France

Drugs / interventions tested

Neurological consultation

Conditions studied

Radiologically Isolated Syndrome (RIS) — all drugs for Radiologically Isolated Syndrome (RIS) →
Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Centre Hospitalier Universitaire de Nīmes

Who can join

Adults 18 to 50, any sex, with Radiologically Isolated Syndrome (RIS) or Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the prevalence of subclinical oculomotor disorders in a population of patients with radiologically isolated syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centre Hospitalier Universitaire de Nīmes trials

Trials by the same sponsor.

NCT07403474 — Combined Use of a Respiratory Multiplex PCR and Algorithm-based Therapy to Improve Early Optimization of Antibiotic Ther · Phase 4 · not yet recruiting
NCT07455981 — Work Organization and Gambling Addiction · not yet recruiting
NCT07403500 — Evaluation of the Short-term Effectiveness of Spinal Manipulation to Treat Acute and Subacute Low Back Pain. · NA · not yet recruiting
NCT07342010 — Bicarbonate Addition to Lidocaine-Epinephrine in Surgery Under WALANT · Phase 4 · not yet recruiting
NCT07305727 — A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03636789 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nīmes
Last refreshed: 18 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03636789.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing